同期ERCP与胆囊切除术可降低手术部位感染风险
该回顾性研究分析2010至2015年2201例胆囊切除术患者,发现开放胆囊切除术的手术部位感染率是腹腔镜的4.1倍(95%CI 1.61-10.24)。术前60天内单独行ERCP者SSI风险显著升高(P=0.04;OR 2.2;CI 1.04-4.49),而同期ERCP不增加SSI风险,推荐对胆总管结石患者采用同期ERCP。
要点
- 开放胆囊切除SSI率是腹腔镜的4.1倍(95%CI 1.61-10.24)。
- 术前60天内行ERCP者SSI风险翻倍(OR 2.2,P=0.04)。
- 同期ERCP不增加SSI风险,应作为胆总管结石首选治疗路径。
核心结论
- 同期ERCP与胆囊切除术不增加SSI风险,应作为胆总管结石患者的首选治疗。
- 术前60天内单独行ERCP使SSI风险翻倍,可能与污染设备及其他因素有关。
研究设计与样本
- 回顾性研究,利用三级学术医院SSI监测数据库,纳入2010至2015年2201例胆囊切除术。
- SSI诊断依据CDC国家医疗安全网络(NHSN)标准,采用逻辑回归模型分析(SAS Studio v3.4企业版)。
主要发现
- 开放胆囊切除术SSI率是腹腔镜的4.1倍(95%CI 1.61-10.24)。
- 调整伤口类别和手术类型后,术前60天内行ERCP者SSI率显著更高(P=0.04;OR 2.2;CI 1.04-4.49)。
- 行ERCP加胆囊切除术者耐药病原体比例显著更高(1.1% vs. 0.2%,P=0.02,Fisher精确检验)。
临床怎么用
- 对胆总管结石患者,优先选择同期ERCP与胆囊切除术以降低SSI风险。
- 避免在胆囊切除术前60天内单独行ERCP,以降低SSI和耐药病原体风险。
局限性
- 回顾性研究设计,可能存在混杂因素。
- 污染设备可能起作用,但其他因素也需考虑。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Cholecystectomy is a common surgical procedure. The presence of common bile duct stones complicates treatment, often requiring a second procedure for stone retrieval. For such patients, endoscopic retrograde cholangiopancreatography (ERCP) provides adequate therapy, and can be performed before, after, or at the same time as cholecystectomy. In 2013, duodenoscopes were implicated by the Centers for Disease Control and Prevention in transmission of carbapenem-resistant Enterobacteriaceae. In this study, we sought to determine if the addition of ERCP to cholecystectomy was associated with higher rates of surgical site infections and microbial resistance. HYPOTHESIS: Adding ERCP to cholecystectomy increases the SSI rate. METHODS: For this retrospective review, we used the SSI surveillance database at our tertiary-care academic hospital. Cholecystectomy cases between 2010 and 2015 were included in the analysis. SSI was diagnosed using criteria of CDC's National Healthcare Safety Network (NHSN). We applied a logistic regression model to our data (SAS Studio software, v3.4, Enterprise Edition). RESULTS: Our 6-year study period included 2201 cholecystectomies. The SSI rate was 4.1 times higher for patients who underwent open cholecystectomy as compared with laparoscopic cholecystectomy (95% CI 1.61-10.24). When adjusted for wound class and procedure type, the SSI rate was significantly higher for patients who underwent ERCP within 60 days before cholecystectomy (P = 0.04; OR 2.2; CI 1.04-4.49). Rates of resistant pathogens were significantly higher in patients who underwent ERCP in addition to cholecystectomy (1.1% vs. 0.2%, P = 0.02, Fisher's exact test). CONCLUSIONS: ERCP performed in the same setting as cholecystectomy carries no increased risk of SSI and should be the treatment of choice in patients with choledocholithiasis. ERCP performed separately within 60 days before cholecystectomy doubles the risk of SSI. Contaminated equipment might play a role, but other factors are likely at play, and should be taken into account when selecting treatment pathways for patients with choledocholithiasis.
引用
- Loor MM, Morancy JD, Glover JK, et al. Single-setting endoscopic retrograde cholangiopancreatography (ERCP) and cholecystectomy improve the rate of surgical site infection. Surg Endosc. 2017. PMID: 28493162. doi:10.1007/s00464-017-5579-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。